Imaging characteristics and safety of florbetapir (18F) in Japanese healthy volunteers, patients with mild cognitive impairment and patients with Alzheimer’s disease

[1] Ferri CP(2005)Global prevalence of dementia: a Delphi consensus study Lancet 366 2112-2117

[2] Prince M(2000)Population aging: a comparison among industrialized countries Health Aff (Millwood) 19 191-203

[3] Brayne C(2012)Prevalence of dementia in Japan: past, present and future Rinsho Shinkeigaku 52 962-964

[4] Brodaty H(2001)Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 56 1143-1153

[5] Fratiglioni L(2013)Amyloid imaging with PET in early Alzheimer disease diagnosis Med Clin N Am 97 377-398

[6] Ganguli M(2013)Amyloid PET in clinical practice: its place in the multidimensional space of Alzheimer’s disease Neuroimage Clin 2 497-511

[7] Anderson GF(2004)Imaging brain amyloid in Alzheimer’s disease with Pittsburgh compound-B Ann Neurol 55 306-319

[8] Hussey PS(2010)Amyloid imaging in early detection of Alzheimer’s disease Neurodegener Dis 7 136-138

[9] Asada T(2009)Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging J Nucl Med 50 818-822

[10] Knopman DS(2008)Imaging of amyloid beta in Alzheimer’s disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism Lancet Neurol 7 129-135

[1] Ferri CP(2005)Global prevalence of dementia: a Delphi consensus study Lancet 366 2112-2117

[2] Prince M(2000)Population aging: a comparison among industrialized countries Health Aff (Millwood) 19 191-203

[3] Brayne C(2012)Prevalence of dementia in Japan: past, present and future Rinsho Shinkeigaku 52 962-964

[4] Brodaty H(2001)Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 56 1143-1153

[5] Fratiglioni L(2013)Amyloid imaging with PET in early Alzheimer disease diagnosis Med Clin N Am 97 377-398

[6] Ganguli M(2013)Amyloid PET in clinical practice: its place in the multidimensional space of Alzheimer’s disease Neuroimage Clin 2 497-511

[7] Anderson GF(2004)Imaging brain amyloid in Alzheimer’s disease with Pittsburgh compound-B Ann Neurol 55 306-319

[8] Hussey PS(2010)Amyloid imaging in early detection of Alzheimer’s disease Neurodegener Dis 7 136-138

[9] Asada T(2009)Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging J Nucl Med 50 818-822

[10] Knopman DS(2008)Imaging of amyloid beta in Alzheimer’s disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism Lancet Neurol 7 129-135